MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jocn.2024.110758

Медицинская библиотека · Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2024

Management of intracranial Rosai-Dorfman disease: An institutional experience.

Tyagi Gaurav, Konar Subhas K, Mehta Sarthak, Nandeesh B, Birua Gyani J S, Saini Jitendra, Sadashiva Nishanth, Shukla Dhaval, Srinivas Dwarakanath, Arivazhagan A, Prabhuraj A R

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

Rosai-Dorfman disease (RDD) is a rare benign proliferative disorder of histiocytes. The study discusses the intracranial RDD approach, its management, and its outcome.

METHODS

It is a retrospective study performed in a tertiary center, the National Institute of Mental Health and Neuroscience, Bangalore, from January 2010 to December 2022. The biopsy-proven patients of RDD were recruited in the present cohort. Demographic and surgical details were collected from the record section, and radiology was collected from the internal storage system. Follow-up assessments were done clinically and telephonically.

RESULTS

A total of 25 patients matched the criteria. The mean age was 32 ± 13.4 years, with male predominance. We have included only cranial cases (N=25). Among the intracranial lesions, 5/25 (20 %) patients had multicentric lesions. All the lesions were avidly enhancing on contrast, and 16 (64 %) lesions were hypointense on T2. Perilesional edema (T2/Flair hyperintensities in the surrounding white matter) was seen in 12 (48 %) patients. Gross total resection (GTR) was carried out in six (24 %) cases. Sub-total resection was in 14 (56 %), and biopsy was in five cases (20 %). Nineteen patients received adjuvant therapy, either only steroid (40 %), only low-dose radiotherapy (16 %), only Chemotherapy (4 %), or a combination of both. At follow-up,44 % of patients had stable disease,28 % had primary disease or recurrence growth, and regression in 12 % of cases.

CONCLUSION

We demonstrate that surgical resection is an effective therapy for treating isolated intracranial RDD. Adjuvant therapy is an add-on treatment for skull base locations in multicentric locations or surgically inaccessible locations.

Для цитирования: Tyagi Gaurav, Konar Subhas K, Mehta Sarthak, Nandeesh B, Birua Gyani J S, Saini Jitendra, Sadashiva Nishanth, Shukla Dhaval, Srinivas Dwarakanath, Arivazhagan A, Prabhuraj A R. Management of intracranial Rosai-Dorfman disease: An institutional experience.. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2024. DOI: 10.1016/j.jocn.2024.110758.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.